Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05280509
What this trial is testing

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Who this might be right for
MyelofibrosisPrimary MyelofibrosisPost-PV MF+1 more
Telios Pharma, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT04217993
What this trial is testing

Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis(Post-PV MF)Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03722407
What this trial is testing

Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

Who this might be right for
Chronic Myelomonocytic LeukemiaLeukemia
H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT02400463
What this trial is testing

A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome

Who this might be right for
Hemophagocytic Syndrome (HPS)
University of Michigan Rogel Cancer Center 6
Not applicableStudy completedNCT07357441
What this trial is testing

Evaluate the Demographics and Treatment Patterns of Myelofibrosis Patients Treated With Ruxolitinib in Turkey

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 355
Testing effectiveness (Phase 2)Study completedNCT01340651
What this trial is testing

Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients

Who this might be right for
Myelofibrosis
Incyte Corporation 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT02131584
What this trial is testing

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03954236
What this trial is testing

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease

Who this might be right for
Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02155465
What this trial is testing

Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Large-scale testing (Phase 3)UnknownNCT04424056
What this trial is testing

A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease

Who this might be right for
Covid19
Assistance Publique Hopitaux De Marseille 216
Testing effectiveness (Phase 2)Study completedNCT03427866
What this trial is testing

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

Who this might be right for
Myelofibrosis
Massachusetts General Hospital 44
Early research (Phase 1)Looking for participantsNCT07278856
What this trial is testing

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

Who this might be right for
Follicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeFollicular Helper T-Cell Lymphoma, Follicular-Type+3 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840456
What this trial is testing

Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck HNSCC
University Hospital, Basel, Switzerland 66
Testing effectiveness (Phase 2)Study completedNCT02475655
What this trial is testing

Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT01644110
What this trial is testing

Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

Who this might be right for
Primary MyelofibrosisSecondary MyelofibrosisPMF+3 more
University of Ulm 96
Early research (Phase 1)Looking for participantsNCT03110822
What this trial is testing

Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 134
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Large-scale testing (Phase 3)Looking for participantsNCT06548360
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Who this might be right for
NonSegmental Vitiligo
Incyte Corporation 180
Testing effectiveness (Phase 2)Study completedNCT05593445
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus

Who this might be right for
Lichen Sclerosus
Incyte Corporation 61
Large-scale testing (Phase 3)Study completedNCT05456529
What this trial is testing

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Incyte Corporation 103
Next Page